MIN-101

DRUG3 trials

Sponsors

Minerva Neurosciences

Conditions

Healthy SubjectsSchizophrenia

Phase 1

Pharmacokinetic Study of MIN-101 in Healthy Subjects

CompletedNCT02232529

Minerva NeurosciencesSchizophrenia

Start: 2014-09-30End: 2015-02-28Updated: 2015-02-24

A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects

CompletedNCT03038646

Minerva NeurosciencesHealthy Subjects

Start: 2016-11-30End: 2017-04-20Updated: 2017-08-31

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

CompletedNCT03072056

Minerva NeurosciencesHealthy Subjects

Start: 2017-01-09End: 2017-07-07Updated: 2017-08-31